Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties.
Sci Rep
; 12(1): 13880, 2022 08 16.
Article
in English
| MEDLINE | ID: covidwho-1991664
ABSTRACT
A series of 1â³-(alkylsulfonyl)-dispiro[indoline-3,2'-pyrrolidine-3',3â³-piperidine]-2,4â³-diones 6aâo has been synthesized through regioselective multi-component azomethine dipolar cycloaddition reaction of 1-(alkylsulfonyl)-3,5-bis(ylidene)-piperidin-4-ones 3aâh. X-ray diffraction studies (6bâd,h) confirmed the structures. The majority of the synthesized analogs reveal promising antiproliferation properties against a variety of human cancer cell lines (MCF7, HCT116, A431 and PaCa2) with good selectivity index towards normal cell (RPE1). Some of the synthesized agents exhibit potent inhibitory properties against the tested cell lines with higher efficacies than the standard references (sunitinib and 5-fluorouracil). Compound 6m is the most potent. Multi-targeted inhibitory properties against EGFR and VEGFR-2 have been observed for the synthesized agents. Flow cytometry supports the antiproliferation properties and shows the tested agents as apoptosis and necrosis forming. Vero cell viral infection model demonstrates the anti-SARS-CoV-2 properties of the synthesized agents. Compound 6f is the most promising (about 3.3 and 4.8 times the potency of the standard references, chloroquine and hydroxychloroquine). QSAR models explain and support the observed biological properties.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Spiro Compounds
/
COVID-19 Drug Treatment
/
Antineoplastic Agents
Limits:
Humans
Language:
English
Journal:
Sci Rep
Year:
2022
Document Type:
Article
Affiliation country:
Egypt
Similar
MEDLINE
...
LILACS
LIS